Cargando…
Erythrocyte membrane in the evaluation of neurodegenerative disorders
Neurodegenerative diseases have many similar pathological conditions, and very few studies exist which detail their molecular features. Proteins like Na(+)/K(+)-ATPase (NKA), α-spectrin (SPTA) and drebrin have been reported to be involved in the integrity of neuronal cell membrane and their function...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6053092/ https://www.ncbi.nlm.nih.gov/pubmed/30050383 http://dx.doi.org/10.2147/DNND.S143989 |
_version_ | 1783340755934248960 |
---|---|
author | Sadanand, Anjana Janardhanan, Anjali Sankaradoss, Arun Vanisree, Arambakkam J Arulnambi, Thamilpavai Bhanu, Kesavamurthy |
author_facet | Sadanand, Anjana Janardhanan, Anjali Sankaradoss, Arun Vanisree, Arambakkam J Arulnambi, Thamilpavai Bhanu, Kesavamurthy |
author_sort | Sadanand, Anjana |
collection | PubMed |
description | Neurodegenerative diseases have many similar pathological conditions, and very few studies exist which detail their molecular features. Proteins like Na(+)/K(+)-ATPase (NKA), α-spectrin (SPTA) and drebrin have been reported to be involved in the integrity of neuronal cell membrane and their functions. Furthermore, recent studies have highlighted their implication in neurodegeneration. In the current study, we wanted to identify the role of NKA, SPTA and drebrin in the erythrocyte membranes obtained from the blood of patients with neurodegenerative disorders (NDs) subjected to motor impairment such as Parkinson’s disease, amyotrophic lateral sclerosis, ataxia and dementia. We have studied the activity of NKA and the expression of NKA, SPTA and drebrin in the erythrocyte membrane by quantitative real-time PCR and Western blot obtained from the blood samples of patients with NDs culminating in movement and memory dysfunction. We observed a significant reduction in the expressions of NKA, SPTA and drebrin when compared to control and significant variations among the recruited ND samples. On correlating, we found a significant relationship between the expressions and the clinical features such as bradykinesia. Thus, we suggest that the reduction in the expressions of NKA, SPTA and drebrin could function as tools of assessment and speculate the particular neurodegenerative condition. |
format | Online Article Text |
id | pubmed-6053092 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-60530922018-07-26 Erythrocyte membrane in the evaluation of neurodegenerative disorders Sadanand, Anjana Janardhanan, Anjali Sankaradoss, Arun Vanisree, Arambakkam J Arulnambi, Thamilpavai Bhanu, Kesavamurthy Degener Neurol Neuromuscul Dis Original Research Neurodegenerative diseases have many similar pathological conditions, and very few studies exist which detail their molecular features. Proteins like Na(+)/K(+)-ATPase (NKA), α-spectrin (SPTA) and drebrin have been reported to be involved in the integrity of neuronal cell membrane and their functions. Furthermore, recent studies have highlighted their implication in neurodegeneration. In the current study, we wanted to identify the role of NKA, SPTA and drebrin in the erythrocyte membranes obtained from the blood of patients with neurodegenerative disorders (NDs) subjected to motor impairment such as Parkinson’s disease, amyotrophic lateral sclerosis, ataxia and dementia. We have studied the activity of NKA and the expression of NKA, SPTA and drebrin in the erythrocyte membrane by quantitative real-time PCR and Western blot obtained from the blood samples of patients with NDs culminating in movement and memory dysfunction. We observed a significant reduction in the expressions of NKA, SPTA and drebrin when compared to control and significant variations among the recruited ND samples. On correlating, we found a significant relationship between the expressions and the clinical features such as bradykinesia. Thus, we suggest that the reduction in the expressions of NKA, SPTA and drebrin could function as tools of assessment and speculate the particular neurodegenerative condition. Dove Medical Press 2017-10-17 /pmc/articles/PMC6053092/ /pubmed/30050383 http://dx.doi.org/10.2147/DNND.S143989 Text en © 2017 Sadanand et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Sadanand, Anjana Janardhanan, Anjali Sankaradoss, Arun Vanisree, Arambakkam J Arulnambi, Thamilpavai Bhanu, Kesavamurthy Erythrocyte membrane in the evaluation of neurodegenerative disorders |
title | Erythrocyte membrane in the evaluation of neurodegenerative disorders |
title_full | Erythrocyte membrane in the evaluation of neurodegenerative disorders |
title_fullStr | Erythrocyte membrane in the evaluation of neurodegenerative disorders |
title_full_unstemmed | Erythrocyte membrane in the evaluation of neurodegenerative disorders |
title_short | Erythrocyte membrane in the evaluation of neurodegenerative disorders |
title_sort | erythrocyte membrane in the evaluation of neurodegenerative disorders |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6053092/ https://www.ncbi.nlm.nih.gov/pubmed/30050383 http://dx.doi.org/10.2147/DNND.S143989 |
work_keys_str_mv | AT sadanandanjana erythrocytemembraneintheevaluationofneurodegenerativedisorders AT janardhanananjali erythrocytemembraneintheevaluationofneurodegenerativedisorders AT sankaradossarun erythrocytemembraneintheevaluationofneurodegenerativedisorders AT vanisreearambakkamj erythrocytemembraneintheevaluationofneurodegenerativedisorders AT arulnambithamilpavai erythrocytemembraneintheevaluationofneurodegenerativedisorders AT bhanukesavamurthy erythrocytemembraneintheevaluationofneurodegenerativedisorders |